PERIPHERAL BLOOD SMEAR FINDINGS AND CLINICAL SIGNIFICANCE IN PREGNANT WOMEN WITH COVID-19
Öz
ABSTRACT
Aim: Peripheral blood smear analysis is a cornerstone diagnostic tool in hematology. Pregnant women with COVID-19, this diagnostic technique assumes heightened significance. Our study aims to elucidate the peripheral smear findings in pregnant women with COVID-19.
Material and Methods: Our study's participants comprise 50 pregnant women diagnosed with COVID-19 and 50 controls. Clinical findings medications, peripheral blood smear and complete blood count parameters some of examined variables. The Chi-Square tests were employed to compare categorical measurements. Samples T-Test was used for numerical measurements. The groups were compared in terms of complete blood count parameters. Significant differences were identified between the groups.
Results: The values of ferritin, CRP, procalcitonin, D-dimer, APTT, and fibrinogen exhibited significant differences among the groups. The lymphocyte ratio in the COVID-19 group is lower compared to the control group. The proportions of band cells, lymphocytes, monocytes, neutrophils, vacuolated monocytes, and hypersegmented neutrophils exhibit statistically significant differences between the groups. Peripheral blood abnormalities are prevalent in microbial infections, particularly in viral infections.
Conclusions: These abnormalities can provide insights into the underlying pathophysiological changes. In patients with COVID-19, no abnormalities have been observed in platelets and erythrocytes. However, compared to controls, atypical monocytes and neutrophil hypersegmentation are significantly elevated in COVID-19 patients.
Anahtar Kelimeler
: COVID-19, Peripheral Blood Smear, Pregnant Women, Complete Blood Count, Lymphocyte Ratio.
Proje Numarası
yok
Kaynakça
- 1. Chase ML, Drews R, Zumberg MS, Ellis LR, Reid EG, Gerds AT, et al. Consensus recommendations on peripheral blood smear review: defining curricular standards and fellow competency. Blood Adv. 2023;7(13):3244–52.
- 2. Surekha M V, Suneetha N, Balakrishna N, Putcha UK, Satyanarayana K, Geddam JJB, et al. Impact of COVID-19 during pregnancy on placental pathology, maternal and neonatal outcome - A cross-sectional study on anemic term pregnant women from a tertiary care hospital in southern India. Front Endocrinol (Lausanne). 2023;14:1092104.
- 3. Chandra S, Tripathi AK, Mishra S, Amzarul M, Vaish AK. Physiological changes in hematological parameters during pregnancy. Indian J Hematol Blood Transfus Off J Indian Soc Hematol Blood Transfus. 2012;28(3):144–6.
- 4. Gajendra S. Spectrum of hematological changes in COVID-19. Am J Blood Res. 2022;12(1):43–53.
- 5. Erol Koç EM, Fındık RB, Akkaya H, Karadağ I, Tokalıoğlu EÖ, Tekin ÖM. Comparison of hematological parameters and perinatal outcomes between COVID-19 pregnancies and healthy pregnancy cohort. 2021;49(2):141–7.
- 6. Ghizlane EA, Manal M, Abderrahim EK, Abdelilah E, Mohammed M, Rajae A, et al. Lymphopenia in Covid-19: A single-center retrospective study of 589 cases. Ann Med Surg. 2021;69:102816.
- 7. Nasif WA, El-Moursy Ali AS, Hasan Mukhtar M, Alhuzali AMH, Yahya Alnashri YA, Ahmed Gadah ZI, et al. Elucidating the Correlation of D-Dimer Levels with COVID-19 Severity: A Scoping Review. Anemia. 2022;2022:9104209.
- 8. Singhania N, Bansal S, Nimmatoori DP, Ejaz AA, McCullough PA, Singhania G. Current Overview on Hypercoagulability in COVID-19. Am J Cardiovasc Drugs [Internet]. 2020;20(5):393–403.
- 9. Elemam NM, Talaat IM, Bayoumi FA, Zein D, Georgy R, Altamimi A, et al. Peripheral blood cell anomalies in COVID-19 patients in the United Arab Emirates: A single-centered study. Front Med. 2022;9:1072427.
- 10. Aminimoghaddam S, Afrooz N, Nasiri S, Motaghi Nejad O, Mahmoudzadeh F. A COVID-19 pregnant patient with thrombotic thrombocytopenic purpura: A case report. J Med Case Rep. 2021;15(1):104.